Chinese Startup Develops Brain-Stimulating Wearable to Combat Obesity

Chinese neurotechnology company BrainCo is developing a wearable device intended to help users manage appetite by stimulating specific regions of the brain, according to recent reports. The innovation represents an attempt to offer a drug-free alternative to GLP-1 receptor agonists, a class of medications that has gained widespread popularity for weight management in recent years.

The device operates on the principle of direct brain stimulation, leveraging advances in wearable neurotechnology to target appetite control mechanisms without pharmaceutical intervention. This approach positions BrainCo's solution as a potential option for individuals seeking alternatives to injectable medications or those unable to tolerate existing pharmaceutical treatments.

The development underscores growing competition in the weight-management technology sector, with companies worldwide exploring innovative approaches beyond traditional pharmaceutical solutions. As demand for obesity treatment options continues to rise globally, particularly in Asia, multiple players are investing in neurotech-based interventions.

While specific details regarding the device's efficacy, safety profile, and timeline for commercialisation remain limited, the project reflects broader industry trends toward non-invasive neurotechnology applications in metabolic health. Regulatory approval processes in China and potential international markets will be critical milestones for the company's commercialisation strategy.